EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Factor XII Deficiency in Mexico: High Prevalence in the General Population and Patients with Venous Thromboembolic Disease

Víctor Manuel Dominguez-Reyes, Jesus Hernandez-Juarez, Rodrigo Arreola-Diaz, Karim Majluf-Cruz, Elba Reyes-Maldonado, José Antonio Alvarado-Moreno, Luis Antonio Moreno Ruiz, Abraham Majluf-Cruz

Archives of Medical Research · 2024

DOI: 10.1016/j.arcmed.2023.102913 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Archives of Medical Research, 2024. Verfasst von Víctor Manuel Dominguez-Reyes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Unit in Thrombosis, Hemostasis and Atherogenesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico; National School of Biol…. Hauptthemen laut MEDLINE: Factor XII Deficiency, Thrombosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Consejo Nacional de Ciencia y Tecnología, Instituto Mexicano del Seguro Social.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Thrombosis is one of the leading causes of morbidity and mortality worldwide. Venous thromboembolic disease (VTD) is considered a new epidemic. FXII deficiency is supposed to be a cause of thrombosis. To search for unknown causes of thrombosis in our population, our aim was to determine if FXII deficiency can be considered a risk factor for VTD. METHODS: Young adult Mexican patients with at least one VTD episode and healthy controls were included in this prospective, observational, controlled study. Liver and renal function tests, blood cytometry, and blood coagulation assays were performed. Plasma FXII activity and its concentration were evaluated. RESULTS: Over a two-year period, 250 patients and 250 controls were included. FXII activity was significantly lower in the control group compared to patients with VTD (p = 0.005). However, percentage of patients and controls with FXII deficiency was 8.8 and 9.2%, respectively (p = 1.000). No significant association was found between FXII deficiency and VTD (p = 1.0). FXII plasma concentration was lower in controls vs. patients with VTD: 4.05 vs. 6.19 ng/mL (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor XII DeficiencyThrombosisHumansYoung AdultMexicoPrevalenceProspective StudiesFactor XII

Stichwörter der Autor:innen

FXIIFXII deficiencyRisk factors for thrombosisThrombosisVenous thromboembolic disease

Substanzen

Factor XII

Autor:innen und Institutionen

  • Medical Research Unit in Thrombosis, Hemostasis and Atherogenesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico; National School of Biological Sciences, Instituto Politécnico Nacional, Mexico City, Mexico.
  • Conacyt-Centro Interdisciplinario de Investigación para el Desarrollo Integral Regional, Unidad Oaxaca, Instituto Politécnico Nacional, Santa Cruz Xoxocotlan, Oaxaca, Mexico.
  • Medical Research Unit in Thrombosis, Hemostasis and Atherogenesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • National School of Biological Sciences, Instituto Politécnico Nacional, Mexico City, Mexico.
  • Cardiology Hospital, CMN SXXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
  • Medical Research Unit in Thrombosis, Hemostasis and Atherogenesis, Instituto Mexicano del Seguro Social, Mexico City, Mexico. Electronic address: amajlufc@gmail.com.

Förderung

  • Consejo Nacional de Ciencia y Tecnología
  • Instituto Mexicano del Seguro Social

Zitieren

APA

Dominguez-Reyes, V. M., Hernandez-Juarez, J., Arreola-Diaz, R., Majluf-Cruz, K., Reyes-Maldonado, E., Alvarado-Moreno, J. A., Ruiz, L. A. M., & Majluf-Cruz, A. (2024). Factor XII Deficiency in Mexico: High Prevalence in the General Population and Patients with Venous Thromboembolic Disease. Archives of Medical Research. https://doi.org/10.1016/j.arcmed.2023.102913

Vancouver

Dominguez-Reyes VM, Hernandez-Juarez J, Arreola-Diaz R, Majluf-Cruz K, Reyes-Maldonado E, Alvarado-Moreno JA, et al. Factor XII Deficiency in Mexico: High Prevalence in the General Population and Patients with Venous Thromboembolic Disease. Archives of Medical Research. 2024. doi:10.1016/j.arcmed.2023.102913

BibTeX
@article{DominguezReyes2024,
  author = {Dominguez-Reyes, Víctor Manuel and Hernandez-Juarez, Jesus and Arreola-Diaz, Rodrigo and Majluf-Cruz, Karim and Reyes-Maldonado, Elba and Alvarado-Moreno, José Antonio and Ruiz, Luis Antonio Moreno and Majluf-Cruz, Abraham},
  title = {Factor XII Deficiency in Mexico: High Prevalence in the General Population and Patients with Venous Thromboembolic Disease},
  journal = {Archives of Medical Research},
  year = {2024},
  doi = {10.1016/j.arcmed.2023.102913}
}
Kostenlos starten →